213 related articles for article (PubMed ID: 8974462)
1. Gadolinium(III) di- and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents.
Martin VV; Ralston WH; Hynes MR; Keana JF
Bioconjug Chem; 1995; 6(5):616-23. PubMed ID: 8974462
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
[TBL] [Abstract][Full Text] [Related]
3. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
[TBL] [Abstract][Full Text] [Related]
4. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
Ladd DL; Hollister R; Peng X; Wei D; Wu G; Delecki D; Snow RA; Toner JL; Kellar K; Eck J; Desai VC; Raymond G; Kinter LB; Desser TS; Rubin DL
Bioconjug Chem; 1999; 10(3):361-70. PubMed ID: 10346865
[TBL] [Abstract][Full Text] [Related]
5. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
6. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
[TBL] [Abstract][Full Text] [Related]
7. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
[TBL] [Abstract][Full Text] [Related]
8. The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents.
McMurry TJ; Parmelee DJ; Sajiki H; Scott DM; Ouellet HS; Walovitch RC; Tyeklár Z; Dumas S; Bernard P; Nadler S; Midelfort K; Greenfield M; Troughton J; Lauffer RB
J Med Chem; 2002 Aug; 45(16):3465-74. PubMed ID: 12139457
[TBL] [Abstract][Full Text] [Related]
9. Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.
Kaneshiro TL; Ke T; Jeong EK; Parker DL; Lu ZR
Pharm Res; 2006 Jun; 23(6):1285-94. PubMed ID: 16729223
[TBL] [Abstract][Full Text] [Related]
10. High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-beta-cyclodextrin.
Battistini E; Gianolio E; Gref R; Couvreur P; Fuzerova S; Othman M; Aime S; Badet B; Durand P
Chemistry; 2008; 14(15):4551-61. PubMed ID: 18386282
[TBL] [Abstract][Full Text] [Related]
11. Prediction of q-values and conformations of gadolinium chelates for magnetic resonance imaging.
Castonguay LA; Treasurywala AM; Caulfield TJ; Jaeger EP; Kellar KE
Bioconjug Chem; 1999; 10(6):958-64. PubMed ID: 10563764
[TBL] [Abstract][Full Text] [Related]
12. Densely packed Gd(III)-chelates with fast water exchange on a calix[4]arene scaffold: a potential MRI contrast agent.
Schühle DT; Polásek M; Lukes I; Chauvin T; Tóth E; Schatz J; Hanefeld U; Stuart MC; Peters JA
Dalton Trans; 2010 Jan; (1):185-91. PubMed ID: 20023949
[TBL] [Abstract][Full Text] [Related]
13. Gd-complexes of macrocyclic DTPA conjugates of 1,1'-bis(amino)ferrocenes as high relaxivity MRI blood-pool contrast agents (BPCAs).
Kim HK; Park JA; Kim KM; Nasiruzzaman SM; Kang DS; Lee J; Chang Y; Kim TJ
Chem Commun (Camb); 2010 Nov; 46(44):8442-4. PubMed ID: 20886175
[TBL] [Abstract][Full Text] [Related]
14. MS-325: albumin-targeted contrast agent for MR angiography.
Lauffer RB; Parmelee DJ; Dunham SU; Ouellet HS; Dolan RP; Witte S; McMurry TJ; Walovitch RC
Radiology; 1998 May; 207(2):529-38. PubMed ID: 9577506
[TBL] [Abstract][Full Text] [Related]
15. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
Werner EJ; Datta A; Jocher CJ; Raymond KN
Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and physicochemical characterization of two gadolinium(III) TTDA-like complexes and their interaction with human serum albumin.
Ou MH; Tu CH; Tsai SC; Lee WT; Liu GC; Wang YM
Inorg Chem; 2006 Jan; 45(1):244-54. PubMed ID: 16390062
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of High Relaxivity Gadolinium AAZTA Tetramers as Building Blocks for Bioconjugation.
Tripepi M; Capuana F; Gianolio E; Kock FVC; Pagoto A; Stefania R; Digilio G; Aime S
Bioconjug Chem; 2018 Apr; 29(4):1428-1437. PubMed ID: 29470084
[TBL] [Abstract][Full Text] [Related]
19. Synthesis neutral rare earth complexes of diethylenetriamine-N,N''-bis(acetyl-isoniazid)-N,N',N''-triacetic acid as potential contrast enhancement agents for magnetic resonance imaging.
Zhang DW; Yang ZY; Wang BD; Zhang SP; Yang RD
Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1203-6. PubMed ID: 16880671
[TBL] [Abstract][Full Text] [Related]
20. Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI.
Lu ZR; Parker DL; Goodrich KC; Wang X; Dalle JG; Buswell HR
Magn Reson Med; 2004 Jan; 51(1):27-34. PubMed ID: 14705042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]